Novozymes
Search results
May 13, 2024 · Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Novo Nordisk is the largest pharmaceutical company in Denmark. Novo Nordisk's market capitalization exceeded the GDP of Denmark's domestic economy in 2023, and it is the highest valued company in Europe.
May 2, 2024 · Learn all about Novo Nordisk in the U.S. and how we're helping to defeat diabetes, rare bleeding disorders, growth hormone-related disorders, and obesity.
Your career guide. At Novo Nordisk, you will have the opportunity to build a life-changing career in a global business environment. Join us and make a difference.
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in discovering and developing treatment for serious chronic disease, like diabetes and obesity.
Apr 20, 2024 · Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.
Novo Nordisk was named as the Best Place in the World to Work in 2022, but our people are what make our company what it is today, and will continue to shape our future. Discovering novel therapies to treat chronic disease for over 100 years. Learn who we are.
Apr 24, 2024 · Our scientists are currently working on novel and innovative treatments to address the unmet needs of people living with diabetes, obesity, haemophilia, growth disorders and non-alcoholic steatohepatitis (NASH). Browse our entire R&D pipeline by study phase, or select a specific therapy areas.
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in serious chronic disease treatment.
Novo Nordisk offers more than 20 medicines for diabetes, chronic weight management, rare bleeding disorders, hormone-related growth disorders and women’s health.
